While genetic data cannot guarantee you won't experience transient brain fog, it helps your clinician select a starting dose and escalation schedule tailored to your physiology, significantly reducing the risk of uncomfortable transitions
During ObesityWeek in November 2024, Viking presented updated data from the previously reported 28-day MAD study of the oral tablet formulation of VK2735, including new results from cohorts dosed at 60 mg, 80 mg, and 100 mg daily
Wegovy is FDA approved for chronic weight management in adults and adolescents 12 years and older with obesity or adults with overweight and at least one weight-related medical condition
October 29, 2024: Novo Nordisk Cited for Quality Lapses at Ozempic Plant The U.S
Storage Guidelines: Prior to reconstitution, the lyophilized powder is highly stable and should be stored away from light at -20C